NCT01846780

Brief Summary

Patients with unilateral post-thrombotic obstruction of the iliac tract and or common femoral vein, eligible for stenting are included. Intravenous pressure is measured in both dorsal foot veins and both common femoral veins. Patients are asked to undergo a standardised treadmill test (3.2km/h, 0% slope that increases by 2%/2min, maximum walking time 26 min). Painfree and maximum action radius are noted.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 1, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 3, 2013

Completed
7 months until next milestone

Study Start

First participant enrolled

December 1, 2013

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
Last Updated

October 21, 2015

Status Verified

October 1, 2015

Enrollment Period

1.5 years

First QC Date

May 1, 2013

Last Update Submit

October 20, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • change in (ambulatory) venous pressure

    measured at the dorsal foot vein and common femoral vein

    0 months, 3months

Secondary Outcomes (4)

  • VCSS

    0 months, 3months

  • Villalta scale

    0 months, 3months

  • Quality of Life

    0 months, 3months

  • Patency

    3 months

Study Arms (1)

Venous outflow obstruction lower limb

Patients with unilateral post-thrombotic iliac vein/common femoral vein obstruction undergoing PTA \& stenting (possibly with additional endophlebectomy and AV-fistula)

Procedure: PTA & stenting

Interventions

PTA \& stenting of the iliac veins and/or common femoral vein. Patients who need to undergo endophlebectomy of the common femoral vein with AV-fistula creation are also included.

Venous outflow obstruction lower limb

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients at our specialized venous outpatient clinic in our tertiary centre

You may qualify if:

  • Indication for stenting (possibly with endophlebectomy and AV-fistula), minimally 18 years of age, life expectancy of at least 6 months.

You may not qualify if:

  • Younger than 18 years of age, life expectancy of less than 6 months, venous obstruction in the contralateral limb, peripheral arterial disease, pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maastricht University Medical Centre

Maastricht, 6202AZ, Netherlands

Location

Related Publications (1)

  • Kurstjens RL, de Wolf MA, Konijn HW, Toonder IM, Nelemans PJ, de Graaf R, Wittens CH. Intravenous pressure changes in patients with postthrombotic deep venous obstruction: results using a treadmill stress test. J Thromb Haemost. 2016 Jun;14(6):1163-70. doi: 10.1111/jth.13333. Epub 2016 May 31.

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples for possible future research

MeSH Terms

Conditions

Postthrombotic SyndromeMay-Thurner Syndrome

Interventions

Stents

Condition Hierarchy (Ancestors)

Venous ThrombosisThrombosisEmbolism and ThrombosisVascular DiseasesCardiovascular DiseasesVenous InsufficiencyVascular MalformationsCardiovascular AbnormalitiesPeripheral Vascular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Prostheses and ImplantsEquipment and Supplies

Study Officials

  • Cees Wittens, MD, PhD

    Maastricht University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 1, 2013

First Posted

May 3, 2013

Study Start

December 1, 2013

Primary Completion

June 1, 2015

Study Completion

June 1, 2015

Last Updated

October 21, 2015

Record last verified: 2015-10

Locations